<DOC>
	<DOCNO>NCT02521012</DOCNO>
	<brief_summary>Depression affect 350 million people worldwide . In light global disease burden statistic , efficacy current treatment depression appear insufficient . Thus , research novel treatment intervention predictor good treatment response warrant . Earlier prospective follow-up study intervention study suggest several bio-psychosocial factor , include high serum concentration vitamin D , related well treatment outcome . In follow-up study randomize clinical vitamin D supplementation trial patient depression , investigator aim 1. clarify six-month intervention vitamin D supplementation affect treatment response , recovery , biological pathway relate depression . This aim find potential sub-groups get benefit vitamin D supplementation . In addition , investigator want 2. investigate characterize factor related recovery depression work ability depression patient long-term . The investigator especially interested bio-psychosocial factor aim include examine individual 's positive resource . The trial start six-month double-blinded randomize control trial vitamin D supplementation . The aim recruit altogether 3028 patient non-psychotic , unipolar depression , age 18-65 year , refer recruitment site treatment depression . The participant randomize low ( 10 µg/day ) high ( 100 µg/day ) vitamin D supplementation group . Clinically necessary antidepressant treatment continue intervention need . After six month intervention , participant follow 18 month 5 year . Several measurement conduct intervention follow-up period . Participants fill variety clinical questionnaire questionnaires background information . All participant give blood sample biomarker analysis time point 3 , 6 , 18 month 5 year . Clinical interview mental disorder ( e.g . SCID ) anthropometric measurement ( e.g . weight , height , blood pressure ) carry .</brief_summary>
	<brief_title>Follow-up Study With Clinical Vitamin D Supplementation Trial Patients With Depression ( DepFuD )</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>patient refer recruitment site treatment depression mild , moderate severe depression , mild , moderate severe episode recurrent depression bipolar psychotic depression psychotic disorder severe substance abuse disabilities sens affect function severely threat complete trial disease affect vitamin D metabolism ( sarcoidosis , hypercalcemia , hypofunction kidney ) pregnancy lactation current use high dose vitamin D supplementation current use high dose calcium supplementation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Depression</keyword>
	<keyword>Depressive symptom</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>Intervention</keyword>
</DOC>